Market revenue in 2023 | USD 198.6 million |
Market revenue in 2030 | USD 346.5 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Modified/ attenuated live |
Fastest growing segment | Other Vaccines |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines |
Key market players worldwide | Boehringer Ingelheim, Zoetis, Merck & Co Inc, Indian Immunologicals, Elanco Animal Health Inc, Virbac SA, Ceva Santé Animale |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ruminant vaccines market will help companies and investors design strategic landscapes.
Modified/ attenuated live was the largest segment with a revenue share of 51.61% in 2023. Horizon Databook has segmented the Middle East & Africa ruminant vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa ruminant vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa ruminant vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account